Inside the beltway

Amending MHPAEA regulatory standards could lower the quality and safety bar for providers to join insurance networks, as well as undermine patient-focused treatment.

Health plan sponsors must know the direct and indirect compensation paid to benefit brokers, consultants and medical and prescription drug claims administrators.

Laws such as Florida's Prescription Drug Reform Act could unravel many of the invaluable protections ERISA has provided.

Data shows that the $5,000 annual tax limit does not cover the average price of one child in center-based infant care.

In the wake of a hastily drafted law that leaves plan sponsors with questions, the goal is to be "as compliant as possible."

The keys to success lie in improved price postings, meaningful action at the state level and grassroots involvement to influence policy.

State actions on paid leave regularly make it harder for employers to continue providing benefits that exceed the programs they created.

High-value care makes employees happier, saves businesses money and drives more patients to high-value healthcare providers.

Proposed legislation would give states, purchasers and researchers the data to paint a comprehensive picture of the state of U.S. healthcare.

Bipartisan support is building to make pharmacy benefit managers more transparent and accountable, which would benefit millions of working Americans.